Alternatives to Eloria

A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included partner if you can live with a yearly plan and a pharmacy it doesn't name.

Compounded semaglutide at $69 a month and tirzepatide at $119, one flat price that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. Both figures are advertised against struck-through list prices of $299 and $399 under a live countdown clock, and the promise to lock that rate for life is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.

The brand-access marketplace: real FDA-approved pens and oral options with insurance-style navigation — but a required video visit, a 28-day billing cycle, and prices that sit well above the compounded field.

A high-volume general telehealth platform, not a GLP-1 specialist — $99 flat for a one-time doctor consultation with no membership, but the medication cost is billed separately and never itemized, so the real monthly total is unknown until you fill the prescription.

AskRx solves the pricing question most of this page leaves open, and creates a different one. Its care fee is itemized in its own footnote — $90/month physician visit, $10/month fulfilment, $100 total — and the medication is billed separately through its own pharmacy, at cost, with both halves shown at checkout. If you have ever wondered how much of a blended monthly price is the drug and how much is margin, this is the provider that answers it. It is FDA-approved only ('No compounded meds'), so the options are the Wegovy pen, the Wegovy pill, Zepbound in pen or KwikPen form, and Foundayo, the oral tirzepatide. All 50 states, board-certified physicians with obesity-medicine training, unlimited messaging, monthly titration, cancel anytime. Two logistics notes that matter on a workday. First, $100 is a floor: no medication price is published, so your real monthly total is unknown until checkout and depends on coverage. Second — and read this one if scheduling is your constraint — 'video visits available in select states' means the async route is not universal here, so confirm your own state before assuming you can do this without a call.

The posted price is half the bill, and the site says so itself. Read live on 26 August 2026, the weight-loss catalog is ten FDA-approved brand listings — Wegovy as a pill and a pen, Zepbound as a vial and a KwikPen, Ozempic in both forms, Mounjaro, and two new oral tablets in the Ozempic Pill and Foundayo — and every single one carries the same footnote: the figure covers medication only, and a membership at $39 for the first month then $149 a month is required and billed separately. So the $149 Wegovy Pill is really about $298 a month and the $299 Zepbound vial is about $448. That membership is not nothing — 24/7 messaging with licensed providers, monthly care-team follow-ups, a smart scale and named in-house clinicians — but it is $1,788 a year on top of the drug. One oddity to open before you buy: Mounjaro and one of two Zepbound listings are posted at a flat $1,899 a month on the same page as Zepbound vials at $299, and nothing explains the gap. Its FAQ asks whether video visits are required and whether all states are served, but keeps both answers inside collapsed panels, so neither could be verified. It carries two FDA warning letters dated 9 September 2025 over the compounded-semaglutide business it has since left behind entirely.

One flat $195/mo plan covers compounded semaglutide, compounded tirzepatide, or a needle-free sublingual option — plus real brand-name access if you want an FDA-approved pen instead — with a women's-health-first framing and a $99 first month, though it won't name your state until you're inside the signup flow.

On logistics Hello Alpha is one of the easiest entries on this page: appointment-free online visits, unlimited provider messaging, free shipping, and a women's health platform behind it rather than a single-product weight-loss funnel. On cost it is one of the hardest to plan for. The $79 a month it publishes is the Alpha Plus+ membership, and the medication is billed on top of it — 'insurance or cash pay', with Hello Alpha stating it will work with your plan to find the lowest cost. It prescribes FDA-approved products only, which is its own stated policy, so the menu is the Zepbound and Mounjaro pens and Rybelsus tablets, and no compounded semaglutide exists here at all. That combination has a clear shape: if your employer plan covers a GLP-1, this is one of the few providers on this page built to use that coverage instead of routing around it, and $79 plus a copay may be the cheapest real outcome available to you. If you are paying cash, the total is unknowable in advance, because no cash medication price is published anywhere on the site, and the compounded providers here will be both cheaper and clearer. Hello Alpha is also explicit that a membership does not guarantee a prescription, which is the right thing to say and worth knowing before you pay.

The arithmetic here is unusually easy to do, because ZipHealth publishes a price for every dose — and unusually easy to get wrong, because none of those prices includes the $79 clinical service and support fee. The FAQ says that fee applies to new and repeat patients, so it recurs. Cheapest genuine month: $149 + $79 = $228. Zepbound at 7.5mg and above: $449 + $79 = $528. What you get for it is the FDA-approved drug rather than a compounded version — there is no compounding here at all.